233 related articles for article (PubMed ID: 26061601)
21. [
Rivera-Marrero S; Fernández-Maza L; León-Chaviano S; Sablón-Carrazana M; Bencomo-Martínez A; Perera-Pintado A; Prats-Capote A; Zoppolo F; Kreimerman I; Pardo T; Reyes L; Balcerzyk M; Dubed-Bandomo G; Mercerón-Martínez D; Espinosa-Rodríguez LA; Engler H; Savio E; Rodríguez-Tanty C
Curr Radiopharm; 2019; 12(1):58-71. PubMed ID: 30605068
[TBL] [Abstract][Full Text] [Related]
22. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
23. Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging.
Kaide S; Ono M; Watanabe H; Shimizu Y; Nakamoto Y; Togashi K; Yamaguchi A; Hanaoka H; Saji H
Bioorg Med Chem; 2018 Jul; 26(12):3352-3358. PubMed ID: 29751990
[TBL] [Abstract][Full Text] [Related]
24. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
25. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
[TBL] [Abstract][Full Text] [Related]
26. A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques.
Yousefi BH; Drzezga A; von Reutern B; Manook A; Schwaiger M; Wester HJ; Henriksen G
ACS Med Chem Lett; 2011 Sep; 2(9):673-7. PubMed ID: 24900362
[TBL] [Abstract][Full Text] [Related]
27. Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques.
Neumaier B; Deisenhofer S; Fürst D; von Arnim CA; Thees S; Buck AK; Glatting G; Landwehrmeyer GB; Krause BJ; Müller HD; Sommer C; Reske SN; Mottaghy FM
Nuklearmedizin; 2007; 46(6):271-80. PubMed ID: 18084683
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
29. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
[TBL] [Abstract][Full Text] [Related]
30. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
Watanabe H; Ono M; Kimura H; Kagawa S; Nishii R; Fuchigami T; Haratake M; Nakayama M; Saji H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6519-22. PubMed ID: 21920750
[TBL] [Abstract][Full Text] [Related]
31. Structure-Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of β-Amyloid Plaques.
Yoshimura M; Ono M; Matsumura K; Watanabe H; Kimura H; Cui M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Saji H
ACS Med Chem Lett; 2013 Jul; 4(7):596-600. PubMed ID: 24900717
[TBL] [Abstract][Full Text] [Related]
32. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
33. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
35. A New Highly Deuterated [
Xiao H; Choi SR; Zhao R; Ploessl K; Alexoff D; Zhu L; Zha Z; Kung HF
ACS Med Chem Lett; 2021 Jul; 12(7):1086-1092. PubMed ID: 34267878
[TBL] [Abstract][Full Text] [Related]
36. Preclinical evaluation of [
Zha Z; Ploessl K; Choi SR; Alexoff D; Kung HF
Nucl Med Biol; 2021 Jan; 92():97-106. PubMed ID: 32245565
[TBL] [Abstract][Full Text] [Related]
37. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
